Journal Title：European Neuropsychopharmacology

European Neuropsychopharmacology is the official publication of the European College of Neuropsychopharmacology (ECNP). In accordance with the mission of the College, the journal focuses on clinical and basic science contributions that advance our understanding of brain function and human behaviour and enable translation into improved treatments and enhanced public health impact in psychiatry. Recent years have been characterized by exciting advances in basic knowledge and available experimental techniques in neuroscience and genomics. However, clinical translation of these findings has not been as rapid. The journal aims to narrow this gap by promoting findings that are expected to have a major impact on both our understanding of the biological bases of mental disorders and the development and improvement of treatments, ideally paving the way for prevention and recovery.

《歐洲神經(jīng)精神藥理學》是歐洲神經(jīng)精神藥理學學院 (ECNP) 的官方出版物。根據(jù)學院的使命，該期刊專注于臨床和基礎(chǔ)科學貢獻，以促進我們對大腦功能和人類行為的理解，并使其轉(zhuǎn)化為更好的治療方法和增強精神病學對公共衛(wèi)生的影響。近年來，神經(jīng)科學和基因組學的基礎(chǔ)知識和可用的實驗技術(shù)取得了令人振奮的進展。然而，這些發(fā)現(xiàn)的臨床轉(zhuǎn)化速度并不快。該期刊旨在通過宣傳有望對我們理解精神障礙的生物學基礎(chǔ)以及治療方法的開發(fā)和改進產(chǎn)生重大影響的發(fā)現(xiàn)來縮小這一差距，理想情況下為預防和康復鋪平道路。

European Neuropsychopharmacology創(chuàng)刊于1990年，由Elsevier出版商出版，收稿方向涵蓋醫(yī)學 - 精神病學全領(lǐng)域，此刊是該細分領(lǐng)域中屬于非常不錯的SCI期刊，在行業(yè)細分領(lǐng)域中學術(shù)影響力較大，專業(yè)度認可很高，所以對原創(chuàng)文章要求創(chuàng)新性較高，如果您的文章質(zhì)量很高，可以嘗試。平均審稿速度 偏慢,4-8周 ，影響因子指數(shù)6.1，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。